安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Overview of Plasma Cell Disorders - The Merck Manuals
The abnormal plasma cells and the antibodies they produce are limited to 1 type, and levels of other types of antibodies that help fight infections fall Thus, people with plasma cell disorders are often at higher risk of infections
- About Multiple Myeloma, Amyloidosis, and Other Plasma Cell Disorders
Signs and symptoms of plasma cell disorders vary from person to person and someone in an early stage of the diseases may have no symptoms, while someone in a later stage may experience a wide range
- Overview of Plasma Cell Disorders - The Merck Manuals
Plasma cell disorders may be suspected because of clinical manifestations, most often bone disease, renal failure, and low blood counts, or an incidental finding of elevated serum protein or proteinuria that leads to further evaluation with serum or urine protein electrophoresis
- Multiple myeloma - Symptoms and causes - Mayo Clinic
Multiple myeloma is a cancer that forms in a type of white blood cell called a plasma cell Healthy plasma cells help fight infections by making proteins called antibodies Antibodies find and attack germs In multiple myeloma, cancerous plasma cells build up in bone marrow
- Plasma Cell Leukemia: Types, Symptoms Prognosis
Having plasma cell leukemia can make your future seem uncertain And you’ll likely experience a flood of different emotions like fear, anger, sadness, frustration or guilt
- Overview of Plasma Cell Diseases and their Clinical Signs and Symptoms
These disorders can range from benign conditions, such as Monoclonal Gammopathy of Undetermined Significance (MGUS), to more serious conditions, such as multiple myeloma and Waldenström macroglobulinemia
- Plasma Cell Disorders and - Mayo Clinic Proceedings
These M proteins can be detected across the spectrum of plasma cell disorders and play an important role in diagnosis, clinical manifestations, and monitoring response to therapy
- Plasma cell dyscrasias - Wikipedia
The condition has been diagnosed based on biopsy-proved clonal plasma cell tumors and or the presence in bone marrow of plasma cells at ≥10% of nucleated cells in individuals who have evidence of end organ damage attributable to an underlying plasma cell disorder
|
|
|